Abstract:Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Although a lower methylation level of whole genome has been demonstrated in TOF patients, little is known regarding the DNA methylation changes in specific gene and its associations with TOF development. NOTCH4 is a mediator of the Notch signalling pathway that plays an important role in normal cardiac development. However, the role of epigenetic regulation of theNOTCH4gene in the pathogenesis of TOF remains unclear. Considering theNOTCH4low mutation frequency and reduced expression in the TOF patients, we hypothesized that abnormal DNA methylation change ofNOTCH4gene may influence its expression and responsible for TOF development. In this study, we measured the promoter methylation status ofNOTCH4and was measured and its regulation mechanism was explored, which may be related to TOF disease. Additionally, the promoter methylation statuses ofNOTCH4was measured in order to further understand epigenetic mechanisms that may serve a role in the development of TOF. Immunohistochemical analysis was used to examine NOTCH4 expression in right ventricular outflow tract myocardial tissues in patients with TOF. Compared with healthy controls, patients with TOF displayed significantly reduced in NOTCH4 expression (P=0.0055). Moreover, bisulphite sequencing suggested that the methylation levels of CpG site 2 in theNOTCH4promoter was significantly higher in the patients than in the controls (P=0.0459). NOTCH4 expression was negatively associated with CpG site 2 methylation levels (r=-0.51; P=0.01). ETS1 transcription factor can serve as transcriptional activators by binding to specific DNA sequences of target genes, such asDLL4andNOTCH4, which serves an important role in normal heart development. Dual-luciferase reporter and electrophoretic mobility shift assays indicated that the ETS1 transcription factor could bind to theNOTCH4promoter region. However, binding of ETS1 to theNOTCH4promoter was abrogated by methylation at the putative ETS1 binding sites. These findings suggested that decreased NOTCH4 expression in patients with TOF may be associated with hypermethylation of CpG site 2 in theNOTCH4promoter region, due to impaired binding of ETS1.

Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

CpG Site Hypomethylation at ETS1‑binding Region Regulates DLK1 Expression in Chinese Patients with Tetralogy of Fallot.

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

DNA methylation status of TBX20 in patients with tetralogy of Fallot

DNA Methylation at CpG Island Shore and RXRα Regulate NR2F2 in Heart Tissues of Tetralogy of Fallot Patients.

CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples

LINE-1 methylation status and its association with tetralogy of fallot in infants

Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification

Promoter Methylation and Expression of the VANGL2 Gene in the Myocardium of Pediatric Patients with Tetralogy of Fallot

Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.

Association Between Mrna Levels Of Dnmt1, Dnmt3a, Dnmt3b, Mbd2 And Line-1 Methylation Status In Infants With Tetralogy Of Fallot

DNA Methylation Status of NKX2-5, GATA4 and HAND1in Patients with Tetralogy of Fallot

Elevated methylation of the RXRA promoter region may be responsible for its downregulated expression in the myocardium of patients with TOF

Identification of miRNA–mRNA–TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot

Tetralogy of Fallot: Variants of MYH6 Gene Promoter and Cellular Functional Analyses

Mirna-940 Reduction Contributes to Human Tetralogy of Fallot Development.

Expression of Cx43-related microRNAs in patients with tetralogy of Fallot

Somatic GATA4 mutation contributes to tetralogy of Fallot

Genetic Variants of ISL1 Gene Promoter Identified from Congenital Tetralogy of Fallot Patients Alter Cellular Function Forming Disease Basis

Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot.

Mitogen-Activated Protein Kinase Signal Pathways Play an Important Role in Right Ventricular Hypertrophy of Tetralogy of Fallot